This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Male Volunteers
and you are
between 20 and 44
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single ascending dose (SAD) administration of E6011 in Japanese healthy volunteers.

Provided treatments

  • Drug: E6011
  • Drug: E6011 Matching Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01731275. The sponsor of the trial is Eisai Co., Ltd. and it is looking for 64 volunteers for the current phase.
Official trial title:
A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects